Lion Point Capital, LP Lumos Pharma, Inc. Transaction History
Lion Point Capital, LP
- $157 Million
- Q1 2024
A detailed history of Lion Point Capital, LP transactions in Lumos Pharma, Inc. stock. As of the latest transaction made, Lion Point Capital, LP holds 90,794 shares of LUMO stock, worth $210,642. This represents 0.16% of its overall portfolio holdings.
Number of Shares
90,794
Previous 90,794
-0.0%
Holding current value
$210,642
Previous $288,000
11.11%
% of portfolio
0.16%
Previous 0.17%
Shares
4 transactions
Others Institutions Holding LUMO
# of Institutions
42Shares Held
2.29MCall Options Held
0Put Options Held
0-
Wells Fargo & Company San Francisco, CA416KShares$964,0780.0% of portfolio
-
Goldman Sachs Group Inc New York, NY407KShares$943,3390.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA244KShares$566,2700.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny218KShares$505,7920.0% of portfolio
-
Acuitas Investments, LLC141KShares$326,3980.21% of portfolio
About LUMOS PHARMA, INC.
- Ticker LUMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,396,070
- Market Cap $19.5M
- Description
- Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare en...